Tzvia Bader Discusses the TrialJectory Platform Connecting Patients With Cancer to Clinical Trials

Article

CancerNetwork® spoke with Tzvia Bader about barriers between patients and appropriate clinical trials and how to combat these issues.

CancerNetwork® sat down with Tzvia Bader, CEO and co-founder of TrialJectory, to discuss the artificial intelligence-powered platform that helps match patients with cancer to appropriate clinical trials.

Bader said that patients who take a proactive role in their treatment, what she terms “activated patients,” are becoming more common in health care today, especially with greater access to information. As a result, patients are taking a more active role in every level of care, from decision making to research regarding viable treatment options. She explains that certain aspects of choosing appropriate therapy, such as individual levels of pain tolerance and the ability to accommodate numerous out-patient visits, is known best by the patients themselves.

In addition, Bader said TrialJectory will help lower barriers to inclusion of a more diverse patient population in clinical trials.

“How can we expect diversity when 85% of patients are being treated in the community setting, but only 10% of community oncologists are having clinical trial discussions with their patients,” Bader said. “We remove the barrier of accessibility…70% of our patients are being treated in the community setting.”

Outside of patient care, TrialJectory may also facilitate progress in the pharmaceutical industry and with contract research organizations who are modeling trials and striving for greater patient inclusion.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences™ Medical World News®, airing daily on all MJH Life Sciences™ channels.

Recent Videos
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 2025 ASCO Annual Meeting, from hot topics and emerging trends to travel recommendations.
The pediatric care wing of the Jack & Sheryl Morris Cancer Center is intended to accommodate the physical and emotional needs of younger patients with cancer.
Having all the necessary staff together, from medical oncologists to pharmacists, helps deliver the best possible outcomes to patients with cancer.
Joseph C. Landolfi, DO, CPE, and Michelle Morrison, MPH, BSHA, RN, discuss how they can use their leadership roles to improve cancer care.
Leadership of a new cancer center as part of JFK University Medical Center discuss how they can support frontline clinicians.
Related Content